|
KR20210035212A
|
|
Mitochondrial expansion therapy for primary mitochondrial disease
|
|
WO2020021539A1
|
|
Mitochondrial augmentation therapy of muscle diseases
|
|
AU2019311862A1
|
|
Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria
|
|
WO2020021534A1
|
|
Mitochondrial augmentation therapy of renal diseases
|
|
WO2020021535A1
|
|
Mitochondrial augmentation therapy of ocular diseases
|
|
WO2020021540A1
|
|
Mitochondrial augmentation therapy of pancreatic diseases
|
|
WO2020021537A1
|
|
Mitochondrial augmentation therapy of liver diseases
|
|
WO2020021538A1
|
|
Mitochondrial augmentation therapy of brain diseases
|
|
EP3773639A1
|
|
Methods for elevation of lipid and cholesterol metabolism
|
|
US2020023005A1
|
|
Mitochondrial compositions and methods for treatment of skin and hair
|
|
CA2977341A1
|
|
Mammalian cells enriched with functional mitochondria
|
|
WO2013171752A1
|
|
Compositions and methods for inducing angiogenesis
|
|
EP2741757A1
|
|
Compositions of functional mitochondria and uses thereof
|
